ID: ALA5089076

Max Phase: Preclinical

Molecular Formula: C30H34N8O3

Molecular Weight: 554.66

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOc1cc(-c2nc3c(C(N)=O)cccc3[nH]2)ccc1Nc1ncc2c(n1)N(C1CCCC1)[C@H](CC)C(=O)N2C

Standard InChI:  InChI=1S/C30H34N8O3/c1-4-22-29(40)37(3)23-16-32-30(36-28(23)38(22)18-9-6-7-10-18)34-20-14-13-17(15-24(20)41-5-2)27-33-21-12-8-11-19(26(31)39)25(21)35-27/h8,11-16,18,22H,4-7,9-10H2,1-3H3,(H2,31,39)(H,33,35)(H,32,34,36)/t22-/m1/s1

Standard InChI Key:  CEEKXOGEUVTDDR-JOCHJYFZSA-N

Associated Targets(Human)

SW1990 722 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Poly [ADP-ribose] polymerase-1 6206 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bromodomain-containing protein 4 13122 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 554.66Molecular Weight (Monoisotopic): 554.2754AlogP: 4.77#Rotatable Bonds: 8
Polar Surface Area: 142.36Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.43CX Basic pKa: 4.60CX LogP: 4.48CX LogD: 4.48
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.28Np Likeness Score: -0.93

References

1. Wang SP, Li Y, Huang SH, Wu SQ, Gao LL, Sun Q, Lin QW, Huang L, Meng LQ, Zou Y, Zhu QH, Xu YG..  (2021)  Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer.,  64  (23.0): [PMID:34813314] [10.1021/acs.jmedchem.1c01535]

Source